These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34250736)

  • 1. Erythema migrans-like rash after Moderna vaccine: An uncommon type of "COVID arm".
    Zengarini C; Artanidi C; Preci C; Gaspari V
    Dermatol Ther; 2021 Sep; 34(5):e15063. PubMed ID: 34250736
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech).
    Kim MJ; Kim JW; Kim MS; Choi SY; Na JI
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e98-e100. PubMed ID: 34661942
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema Migrans-like COVID Vaccine Arm: A Literature Review.
    Fasano G; Bennardo L; Ruffolo S; Passante M; Ambrosio AG; Napolitano M; Provenzano E; Nisticò SP; Patruno C
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine.
    Abobaker A; Idris MA; Ogunjimi O
    Int J Infect Dis; 2022 Jan; 114():29-30. PubMed ID: 34742927
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.
    Altayeb A; Cordaro A; Caesar J; Vyas J; Ingram J
    Int J Dermatol; 2020 Dec; 59(12):1541-1542. PubMed ID: 33084036
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine.
    Ackerman M; Henry D; Finon A; Binois R; Esteve E
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e423-e425. PubMed ID: 33783017
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
    Lindgren AL; Austin AH; Welsh KM
    J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A red and swollen arm after vaccination for covid-19].
    De Mik D; Schot LJ; Privé B
    Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 34854640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDRIFE-like rash in COVID-19 patient: drug reaction or another cutaneous manifestation of SARS-CoV-2?
    Bevilaqua M; Ribolli GB; Luzzatto L; Fernandes JC; Pasqualotto AC; Bonamigo RR
    Int J Dermatol; 2021 Jul; 60(7):884-885. PubMed ID: 33719051
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on "An Isolated Peculiar Gianotti-Crosti Rash in the Course of a COVID-19 Episode".
    Veraldi S; Beretta AE; Marletta DA; Wei Y
    Acta Derm Venereol; 2021 Feb; 101(2):adv00399. PubMed ID: 33554263
    [No Abstract]   [Full Text] [Related]  

  • 12. Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report.
    Kong J; Cuevas-Castillo F; Nassar M; Lei CM; Idrees Z; Fix WC; Halverstam C; Mir A; Elbendary A; Mathew A
    J Infect Public Health; 2021 Oct; 14(10):1392-1394. PubMed ID: 34294590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
    Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND
    Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'COVID arm' - histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine.
    Kempf W; Kettelhack N; Kind F; Courvoisier S; Galambos J; Pfaltz K
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e730-e732. PubMed ID: 34242422
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "Are erythema multiforme and urticaria related to a better outcome of COVID 19?" Eosinophil count in seven patients with COVID-19 and urticarial rash.
    Jimenez-Cauhe J; Ortega-Quijano D; Suarez-Valle A; Dominguez-Santas M; Diaz-Guimaraens B; Fernandez-Nieto D
    Dermatol Ther; 2020 Nov; 33(6):e13844. PubMed ID: 32544263
    [No Abstract]   [Full Text] [Related]  

  • 16. [SARS-COV-2 infection and skin manifestations].
    Schuhler C; Alberto C; Toutous-Trellu L; Kaya G
    Rev Med Suisse; 2021 Mar; 17(732):642-645. PubMed ID: 33793102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
    Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
    Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Mar; 174(3):JC28. PubMed ID: 33646836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician-diagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites.
    Masters E; Granter S; Duray P; Cordes P
    Arch Dermatol; 1998 Aug; 134(8):955-60. PubMed ID: 9722725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash.
    Stoyanov A; Thompson G; Lee M; Katelaris C
    Ann Allergy Asthma Immunol; 2022 Mar; 128(3):321-322. PubMed ID: 34813953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.